845: Urinary Levels of Tumor-Associated Trypsin Inhibitor (TATI) in the Detection of Transitional Cell Carcinoma of the Urinary Bladder

Abstract

You have accessJournal of UrologyPodium, Monday, May 23, 2005, 1:00 - 3:00 pm1 Apr 2005845: Urinary Levels of Tumor-Associated Trypsin Inhibitor (TATI) in the Detection of Transitional Cell Carcinoma of the Urinary Bladder Shahrokh F. Shariat, Mike Herman, Roberto Casella, Yair Lotan, Jose Karam, and Ulf-Håkan Stenman Shahrokh F. ShariatShahrokh F. Shariat More articles by this author , Mike HermanMike Herman More articles by this author , Roberto CasellaRoberto Casella More articles by this author , Yair LotanYair Lotan More articles by this author , Jose KaramJose Karam More articles by this author , and Ulf-Håkan StenmanUlf-Håkan Stenman More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)35014-6AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "845: Urinary Levels of Tumor-Associated Trypsin Inhibitor (TATI) in the Detection of Transitional Cell Carcinoma of the Urinary Bladder." The Journal of Urology, 173(4S), pp. 229–230 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 173Issue 4SApril 2005Page: 229-230 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Shahrokh F. Shariat More articles by this author Mike Herman More articles by this author Roberto Casella More articles by this author Yair Lotan More articles by this author Jose Karam More articles by this author Ulf-Håkan Stenman More articles by this author Expand All Advertisement Loading ...